DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

S H Kelkar and Company Limited — Credit Rating

NSE 1 hr ago·28 Sept 2026, 10:47 am

SKYBIOTECH NSE

S H Kelkar and Company Limited has informed stock exchanges that it has received a credit rating. This rating is an independent assessment of the company's ability to repay its financial obligations and manage its debt levels.

For investors, this development is a key indicator of financial health. A rating provides a snapshot of the company's creditworthiness, which can influence its borrowing costs and overall market perception. It helps gauge the risk associated with the company's debt obligations.

Investors should monitor the specific rating agency's report to understand the assigned grade and the rationale behind it. This information will clarify the current financial standing and help assess the company's stability in the market.